Cardiometabolic risk factors in women with non-classic congenital adrenal hyperplasia
- 20 September 2019
- journal article
- research article
- Published by Taylor & Francis in Acta Cardiologica
- Vol. 75 (8) , 705-710
Abstract
Background: No previous study has investigated cardiometabolic risk factors in untreated patients with congenital adrenal hyperplasia (CAH). Methods: The study population consisted of 14 premenopausal women with previously untreated non-classic congenital adrenal hyperplasia (NC-CAH) and 20 matched healthy women. Apart from 17-hydroxyprogesterone and androgen levels, the outcomes of interest were glucose homeostasis markers, plasma lipids, plasma levels of uric acid, C-reactive protein, fibrinogen, homocysteine and 25-hydroxyvitamin D, as well as urinary albumin-to-creatinine ratio (UACR). Results: As expected, women with NC-CAH were characterised by higher levels of 17-hydroxyprogesterone and were more insulin-resistant than control women. The mean values of C-reactive protein, fibrinogen, homocysteine and UACR were higher while 25-hydroxyvitamin D levels were lower in subjects with NC-CAH. The investigated cardiometabolic risk factors correlated with androgen levels and insulin sensitivity. Conclusions: The obtained results suggest that the occurrence of NC-CAH in premenopausal women may increase cardiometabolic risk.Keywords
This publication has 25 references indexed in Scilit:
- Circulating 25-Hydroxy-Vitamin D and Risk of Cardiovascular DiseaseCirculation: Cardiovascular Quality and Outcomes, 2012
- MECHANISMS IN ENDOCRINOLOGY: Recent advances in cardiovascular aspects of polycystic ovary syndromeEuropean Journal of Endocrinology, 2012
- Differential Diagnosis of Hyperandrogenism in Women with Polycystic Ovary SyndromeExperimental and Clinical Endocrinology & Diabetes, 2012
- Microalbuminuria: Marker or Maker of Cardiovascular DiseaseNephron Experimental Nephrology, 2011
- PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysisHuman Reproduction Update, 2011
- Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice GuidelineThe Journal of Clinical Endocrinology & Metabolism, 2010
- Unfavourable trends in cardiovascular and metabolic risk in paediatric and adult patients with congenital adrenal hyperplasia?Clinical Endocrinology, 2010
- Inflammatory Biomarkers in Stable AtherosclerosisThe American Journal of Cardiology, 2006
- Effects of HMG-CoA Reductase Inhibitors on Coagulation and Fibrinolysis ProcessesDrugs, 2003
- Morbidity and mortality in Cushing's disease: an epidemiological approachClinical Endocrinology, 1994